dermatology

News

Third FDA rejection for Verrica's molluscum contagiosum drug

Shares in US biotech Verrica Pharma lost half their value today after the FDA declined to approve its candidate treatment for viral skin infection molluscum contagiosum for a third time.

News

Dermavant claims its first approval as FDA clears psoriasis ...

Roivant group company Dermavant has made the transition to a commercial-stage company after getting FDA approval for Vtama, a drug for psoriasis that it claims could be a game-changer in th

News

Sidekick and Pfizer prep launch of DTx for atopic dermatitis

A long-running partnership between digital therapeutics (DTx) developer Si

News

Happify says study backs value of its wellbeing app in psori...

People with psoriasis who used an app developed by digital health company Happify reported reduced anxiety and improvements in mental wellbeing in a real-world study involving more than two

News

Joe Wiley, chief executive, Amryt_Pharma

FDA turns down Amryt's epidermolysis bullosa drug

Amryt Pharma has been handed a major blow by the FDA, after the US regulator rejected its marketing application for Oleogel-S10, its drug for rare and debilitating skin disease epidermolysi

News